← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2011Last known activity
Oct 31, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT04780152CollaboratorPhase 2/Phase 3Oct 31, 2021
- NCT04020588Lead sponsorPhase 4Feb 25, 2019
- NCT02573701Reponsible party - principal investigatorN/AOct 1, 2011
- NCT02573701Lead sponsorN/AOct 1, 2011
Details
- Last known activity
- Oct 31, 2021